Additionally, research has identified that lobaplatin can initiate pyroptosis in CRC via GSDME, enhancing ROS levels and activating the c-jun N-terminal kinase (JNK), leading to caspase-3/9 activation through the ROS/JNK/BAX mitochondrial apoptosis pathway (75). Here, GSDME is linked to colorectal carcinoma.